Zobrazeno 1 - 10
of 24
pro vyhledávání: '"33"'
Autor:
Etienne, De Braekeleer, Nathalie, Douet-Guilbert, Frédéric, Morel, Marie-Josée, Le Bris, Audrey, Basinko, Christian, Berthou, Patrick, Morice, Claude, Férec, Marc, De Braekeleer
Publikováno v:
Anticancer research. 30(2)
The Philadelphia (Ph) chromosome, resulting from a t(9;22)(q34;q11), is one of the most frequent chromosomal abnormalities observed among patients with acute lymphoblastic leukemia (ALL). Main of study: To analyze the distribution of Ph chromosome-po
Autor:
Hideo Baba, Taishi Yamane, Shinya Shimada, Kei Horino, Daisuke Izumi, Chika Shirakami, Keisuke Morita, Satoshi Ikeshima, Shotaro Kinoshita
Publikováno v:
Anticancer Research. 41:5223-5229
AIM The aim of the current study was to investigate whether the artery-first approach (AFA) improved surgical outcomes of pancreaticoduodenectomy (PD) at our non-high-volume center. PATIENTS AND METHODS We retrospectively reviewed data on 121 consecu
Autor:
Takahiko Nakamura, Kenjiro Tsuruoka, Kiyoe Kanaoka, Yosuke Tamura, Yasuhito Fujisaka, Soichiro Ikeda, Tomoya Funamoto, Masafumi Imanishi, Isao Goto, Akihisa Imagawa, Hiroyuki Tsuji, Sho Mitsuya, Ninso Matsunaga
Publikováno v:
Anticancer Research. 41:5137-5145
BACKGROUND For epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), administration of EGFR tyrosine kinase inhibitors (TKIs) is mandatory to prolong survival. To date, a comparison of second- and third-generation EGFR-T
Publikováno v:
Anticancer research. 42(6)
The aim of the study was to determine outcomes and overall survival (OS) in patients undergoing cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for malignant peritoneal mesothelioma (MPM).This was a retrospective cohort st
Autor:
YUKARI BANDO, JUNYA FURUKAWA, YASUYOSHI OKAMURA, TAKUTO HARA, TOMOAKI TERAKAWA, YUZO NAKANO, MASATO FUJISAWA
Publikováno v:
Anticancer research. 42(2)
The survival benefit of immune checkpoint inhibitors for non-clear cell renal cell carcinoma (nccRCC) is unclear. Our purpose was to evaluate the real-world survival benefit of ipilimumab plus nivolumab retrospectively.We retrospectively reviewed med
Autor:
Takayuki Shiraki, Takatsugu Matsumoto, Takamune Yamaguchi, Yukihiro Iso, Yuhki Sakuraoka, Taku Aoki, Keiichi Kubota, Shozo Mori, Takayuki Shimizu, Kyung Hwa Park
Publikováno v:
Anticancer research. 41(10)
BACKGROUND/AIM The efficacy and feasibility of gemcitabine plus cisplatin (GC) chemotherapy in an adjuvant setting is unclear in patients with biliary tract cancer (BTC) undergoing major hepatectomy. PATIENTS AND METHODS Patients with BTC who underwe
Publikováno v:
Anticancer research. 17(3C)
A retrospective analysis of para-aortic lymph node (PALN) metastasis in patients with cervical squamous cell cancer who received prophylactic postoperative irradiation to the pelvis, was carried out.Sixty-seven patients had no intra-pelvic lymph node
Publikováno v:
Anticancer research. 40(7)
Background/aim CHORUS and EORTC55971 trials demonstrated that neoadjuvant chemotherapy followed by interval debulking surgery (IDS) or primary debulking surgery (PDS) offered the same survival rates. These trials have since been criticised due to poo
Autor:
Takaaki, Fujii, Toshinaga, Sutoh, Hiroki, Morita, Reina, Yajima, Satoru, Yamaguchi, Soichi, Tsutsumi, Takayuki, Asao, Hiroyuki, Kuwano
Publikováno v:
Anticancer research. 34(6)
We previously showed that the presence of vascular invasion, but not lymphatic invasion, was a strong prognostic factor for breast cancer. Lymphatic invasion may represent mainly the selective affinity of cancer cells for lymph nodes. The present stu
Autor:
Sheng-En, Chou, Chun-Ying, Huang, Shyr-Ming, Sheen-Chen, Yueh-Wei, Liu, Ching-Hua, Tsai, Yu-Hung, Lin, Chao-Cheng, Huang, Rei-Ping, Tang
Publikováno v:
Anticancer research. 31(10)
The benefit of tissue microarray (TMA) is its capability to analyse large numbers of tissue samples in a uniform fashion. This study was designed to evaluate the capability of TMA for analyzing the status of death-associated protein kinase 1 (DAPK1)